Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
Withdrawn before enrolling
Conditions studied: Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Hematologic Cancer
In brief
The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.
Key facts
- Study ID
- NCT01792882
- Run by
- Global BioClinical
- People needed
- 0
- Starts
- 2013-02-01
- Expected to finish
- 2023-02-27
- Last updated by the study team
- 2023-02-28
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Any adult age
- Any sex
- Able to provide consent for surplus tissue and/or blood donation
- Diagnosed with one of the cancer indications listed below:
- Scheduled to undergo surgical resection of tumor (exception for hematological cancers)
- Have not yet received treatment for cancer
You may not qualify if…
- Not diagnosed with required cancer indication
- Not scheduled to undergo surgical resection of the tumor
- Have already received cancer treatment (such as chemotherapy, radiation, surgery) for the current cancer or a previously diagnosed cancer
- Not able to donate an adequate volume of blood to meet minimum requirements
- CANCER INDICATIONS:
- Bladder Cancer - Urothelial carcinoma - nonpapillary
- Bladder Cancer - Urothelial carcinoma - papillary
- Brain Cancer - Astrocytoma
- Brain Cancer - Glioblastoma
- Brain Cancer - Medulloblastoma
- Breast Cancer - Ductal Carcinoma
- Breast Cancer - Lobular Carcinoma
- Cervical Cancer - Squamous Cell Carcinoma
- Colorectal Cancer - Adenocarcinoma
- Esophageal Cancer - Adenocarcinoma
- Gastric Cancer
- Head and Neck Cancer - Squamous Cell Carcinoma
- Hematologic Cancer - Acute Lymphocytic Leukemia (ALL)
- Hematologic Cancer - Acute Myeloid Leukemia (AML)
- Hematologic Cancer - Chronic Lymphocytic Leukemia (CLL)
- Hematologic Cancer - Diffuse Large B-cell Lymphoma
- Hematologic Cancer - Multiple Myeloma (MM)
- Hematologic Cancer - Non-Hodgkins Lymphoma (NHL)
- Kidney Cancer - Papillary Carcinoma
- Kidney Cancer - Renal cell Carcinoma
Where it is running
- GBC — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.